Structure-Based Discovery of Dual Pathway Inhibitors for SARS-CoV-2 Entry

Investigators identified compounds that showed potent inhibition of these proteases and determine their complex structures with their respective targets. Furthermore, they showed that applying inhibitors simultaneously that block both entry pathways had a synergistic antiviral effect.